Turkey Restructures Reimbursement Body But Is It Enough?
This article was originally published in PharmAsia News
Turkey has designated health sciences, and the pharmaceutical industry in particular, as a strategic sector to support economic development, and the government appears determined to turn the country into a regional hub by supporting production and high-value exports. The national reimbursement body has recently been restructured to promote these goals but the industry is cautious.
Register for our free email digests: